Table 1.
Characteristics of At-Risk, Human Immunodeficiency Virus–Negative Women
| Characteristic | Study Group |
P Value | |||
|---|---|---|---|---|---|
| DMPA (n = 32) | LNG-IUD (n = 27) | OCP (n = 32) | No Hormonal Contraception (n = 33) | ||
| Age at visit, y | 32.5 (30.1–34.9) | 35.6 (32.6–38.6) | 33.7 (31.6–35.8) | 33.3 (31.8–34.8) | .26 |
| Race | .11 | ||||
| White, non-Hispanic | 1 (3.1) | 4 (14.8) | 7 (21.9) | 2 (6.1) | |
| Black, non-Hispanic | 20 (62.5) | 10 (37.0) | 11 (34.4) | 22 (66.7) | |
| Hispanic | 8 (25.0) | 10 (37.0) | 11 (34.4) | 8 (24.2) | |
| Other | 3 (9.4) | 3 (11.1) | 3 (9.4) | 1 (3.0) | |
| Education level | .02 | ||||
| Less than college | 27 (84.4) | 15 (55.6) | 16 (50.0) | 22 (66.7) | |
| College or greater | 5 (15.6) | 12 (44.4) | 16 (50.0) | 11 (33.3) | |
| CD4+ T-cell count at visit, cells/μL | 911 (794–1028) | 1090 (869–1312) | 953 (768–1137) | 1168 (1031–1305) | .05 |
| Current smoker at visit | 13 (40.6) | 10 (37.0) | 7 (21.9) | 11 (33.3) | .11 |
| Years of smoking | 7.8 (4.2–11.4) | 9.1 (4.8–13.3) | 5.5 (2.9–8.1) | 6.6 (3.7–9.6) | .63 |
Data are mean value (95% confidence interval) or no. (%) of participants.
Abbreviations: DMPA, depot medroxyprogesterone acetate; LNG-IUD, levonorgestrel intrauterine device; OCP, oral contraceptive pills.